Fighting Blood Cancers with New and Innovative Treatments
September is Blood Cancer Awareness Month and Dr. Caron Jacobson, MD, Clinical Director, Immune Effector Cell Therapy Program, Dana-Farber Cancer Institute discusses the blood cancers lymphoma and leukemia and CAR T therapies.
Frequently Asked Questions
What is the main topic discussed in this episode of Health Professional Radio?
This episode covers important developments in healthcare, including updates on Cancer. Health Professional Radio brings you expert insights and analysis on the latest medical news affecting healthcare professionals and patients alike.
How can healthcare professionals benefit from this information?
Healthcare professionals can stay informed about the latest developments in Cancer and related fields, enabling them to provide better patient care. Staying current with medical news helps clinicians make evidence-based decisions in their practice.
Where can I find more information about Cancer?
For more detailed information, listen to the full episode on Health Professional Radio and visit hpr.fm for additional resources. You can also subscribe to our podcast for regular updates on healthcare news and expert interviews.
Caron Jacobson is an Assistant Professor of Medicine at Harvard Medical School and a member of the lymphoma group at the Dana-Farber Cancer Institute. She treats lymphoma patients and oversees clinical trials in B cell non-Hodgkin lymphoma. She participates in and runs industry-sponsored and investigator-initiated trials.
Most of Caron’s research is in engineered and CAR T-cell therapies. She is the medical director of the Immune Effector Cell Therapy program at Dana-Farber, overseeing the multidisciplinary efforts in CAR T-cell, engineered TCR T-cells, and NK cell therapies.
Medical Disclaimer
The information provided on this website is for general informational purposes only and is not intended as medical advice. Always consult with a qualified healthcare professional for medical advice, diagnosis, or treatment. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.
